Immunofluorescent staining was performed in human AAA tissue with antibodies against Hes1 (a downstream target genes of NICD) and α-smooth muscle-actin (α-SMA) (a marker for smooth muscle cells). The gene discussed is HES1; the disease is triple-A syndrome.